Posts filtered by tags: Alzheimer[x]


 

Alzheimer's nasal vaccine to enter human trials for the first time, spurring renewed hope for preventing the disease

A laboratory worker tests a nasal spray (not related to Alzheimer's) at the Pharma and Beauty factory in Saint-Chamas, France, on January 21, 2021.Nicolas Tucat/AFP/Getty Images Brigham and Women's Hospital is spearheading the first human trial of an Alzheimer's nasal vaccine. The vaccine is designed to prevent or slow the progression of the disease. It uses a drug, Protollin, to stimulate immune cells to remove sticky plaque from the brain. Alzheimer's treatments seemed like ...
Tags: Science, News, Drugs, US, Trends, Alzheimer's Disease, Food And Drug Administration, Fda, Vaccines, Eisai, Cummings, Brigham, Alzheimer, University of Nevada Las Vegas, William Burke, Biogen


As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's

Beam Therapeutics cofounder David Liu.Jessica Rinaldi/The Boston Globe via Getty Images Scientist and biotech cofounder David Liu is one of the pioneers of drugs that can edit DNA. His lab is developing therapy that could prevent Alzheimer's by installing a protective gene. Liu was named one of Insider's 100 People Transforming Business in 2021. David Liu is best known as one of the pioneers of the experimental science of editing people's genes.Liu's laboratory at the Br...
Tags: Trends, Harvard, Alzheimer's Disease, Healthcare, Biotech, Boston Globe, Broad Institute of MIT, Liu, Huang, Alzheimer, Gladstone Institutes, Gene Therapy, David Liu, Yadong Huang, Alzheimer's Drugs, Beam Therapeutics


UMass Amherst and Brigham launch MassAITC to improve in-home care for Alzheimer's patients

The University of Massachusetts Amherst and Brigham and Women's Hospital announced today the launch of the new Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MassAITC), which seeks to improve in-home care for older adults and individuals with Alzheimer's disease, thanks to a grant from the National Institute on Aging (NIA), which is part of the National Institutes of Health.
Tags: Health, Brigham, Alzheimer, University of Massachusetts Amherst, UMass Amherst, National Institute on Aging NIA


After over a decade of marriage, husband with Alzheimer's falls in love with his wife again

After over a decade of marriage, Peter Marshall was diagnosed with Alzheimer's and forgot he was married. So he fell back in love with his wife, Lisa.       [Author: USA TODAY]
Tags: Usa, News, Usa Today, Peter Marshall, Lisa, Alzheimer


"Peter now needs constant supervision and does not appear to remember his second wedding."

"Soon Lisa will probably have to place him in a care home, but for now they can still live together. 'My mantra has always been to have no regrets,' said Lisa, who worked in radio advertising. The couple met in 2001 after both went through divorces while neighbours in Harrisburg, Pennsylvania. They have five children between them. When Lisa joined her husband to exchange vows for the second time, his delight was clear for all to see. 'It was just magical — straight out of a fairytale,' she said...
Tags: Marriage, Law, Memory, Weddings, Alzheimer's, Peter, Lisa, Alzheimer, Harrisburg Pennsylvania, Ann Althouse, Holyoke Massachusetts London


The FDA approved a controversial, $56,000-a-year Alzheimer's drug despite opposition inside the agency, internal memos show

Atthapon Raksthaput/Shutterstock The approval of Biogen's new Alzheimer's drug has been widely debated and led regulatory three advisors to resign. New documents show that FDA experts were divided on the drug. Two of the people involved in reviewing the drug said hadn't been shown to slow down the disease. See more stories on Insider's business page. Regulatory advisors and Alzheimer's disease experts have decried the approval of a controversial new treatment since it...
Tags: America, Trends, Food And Drug Administration, Fda, Alzheimer, Biogen, Massie, Center for Biologics Evaluation and Research, Peter Stein, Peter Marks, Center for Drug Evaluation and Research, Allison DeAngelis, Patrizia Cavazzoni, Aduhelm, Sylva Collins, Tristan Massie


Could flickering lights fight Alzheimer's? Early research looks promising

For the past few years, Annabelle Singer and her collaborators have been using flickering lights and sound to treat mouse models of Alzheimer's disease, and they've seen some dramatic results.Now they have results from the first human feasibility study of the flicker treatment, and they're promising."We looked at safety, tolerance, and adherence, and several different biological outcomes, and the results were excellent—better than we expected," says Singer, assistant professor in the biomedical ...
Tags: Health, Medicine, Georgia, Brain, Medical Research, Innovation, Emory, Wright, Georgia Institute of Technology, Alzheimer, Lah, Human body, Annabelle Singer, Emory University Singer, American Neurological Association, James Lah


Healthy Habits: New Alzheimer's Drug

On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes the recent FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.Brought to you by: Frugal Focus
Tags: Fda, Frugality, Alzheimer, Alzheimer 's Association, Biogen Eisai


Elemental copper and iron found within the brains of deceased Alzheimer's patients

A new study unexpectedly identified tiny deposits of elemental copper and iron within the brains of two deceased people with Alzheimer's disease. The findings could help scientists better understand how these elemental metals, which were uncovered in the cores of amyloid plaques, contribute to neurodegenerative diseases and could point to a target for alternative Alzheimer's therapies.
Tags: Science, Alzheimer


Why California has a giant 1950s town replica

Glenner Town Square looks like a 1950s town, but it's actually a treatment center in Chula Vista, California, for people with Alzheimer's disease and dementia. The center uses reminiscence therapy to help spark memories and provide a comforting environment for aging patients. The FDA just approved an Alzheimer's treatment on Monday, ushering in the first new drug for the disease in nearly two decades. Visit Business Insider's homepage for more stories. Following is a transcript...
Tags: California, Trends, Healthcare, San Diego, Fda, Eva, Chula Vista, Scott, Town Square, Alzheimer, Sonia, Chula Vista California, Sonia She, Glenner Town Square, Alyssa Pagano, George Glenner


Biogen soars 64% after FDA approves first new Alzheimer's drug in 18 years

The Biogen headquarters in Cambridge, Mass. AP Photo/Steven Senne Biogen soared as much as 64% on Monday after the US FDA approved the company's Alzheimer's treatment. The approval marks the first new Alzheimer's disease treatment in nearly two decades. An FDA advisory committee in November last year had concluded the drug did not effectively treat the disease. Sign up here for our daily newsletter, 10 Things Before the Opening Bell. Shares of Biogen soared as much as 64% to th...
Tags: US, Trends, Fda, US Food and Drug Administration, Alzheimer, Cambridge Massachusetts, Biogen, Cambridge Mass, Michel Vounatsos, Center for Drug Evaluation and Research, Isabelle Lee, Patrizia Cavazzoni, Steven Senne Biogen


The FDA just approved the first new Alzheimer's drug in 18 years

Dr. William Burke going over a PET brain scan at Banner Alzheimer's Institute in Phoenix. Biogen's drug was tested against carriers of the APOE gene, which is linked to Alzheimer's, and non-carriers. Matt York/Associated Press The FDA on Monday approved the first new Alzheimer's disease treatment in nearly two decades. Biogen had initially deemed the drug a failure and shut down two late-stage trials. Experts were divided on the drug. One analyst had estimated a 15% chance ...
Tags: Science, News, Trends, Alzheimer's Disease, Healthcare, Food And Drug Administration, Fda, Biotech, Agency, Citi, Alzheimer, William Burke, RBC Capital Markets, Biogen, Eli Lilly, Namenda


Scientists are reaching a new understanding about Alzheimer's disease

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back after a week away to ski and feeling refreshed. Today in healthcare news:Scientists have a new way of thinking about Alzheimer's disease;Pfizer's and Moderna's shots are 90% effective out in the real world;See the investor presentation Crossover Health gave at a January investor conference.If you're new to this newsletter, sign up here. Comments, tips, tricks for successfully scheduling vaccine appointments ...
Tags: Amazon, Colorado, Cdc, America, Trends, Alzheimer's Disease, Healthcare, Pfizer, Vaccine, Nevada, Reno, Alzheimer, Midtown Manhattan, Newsletters, Moderna, Skye Gould


AREAA Commentary: Learning Not to Hate, Education Is Key

Hate crimes against Asian Americans are on the rise, prompting admonishment from the highest level of our country’s leadership. President Joe Biden, during a March 11 prime time address from the White House, called these actions “un-American,” saying they must stop. As I write this article, eight women were killed in Atlanta just yesterday, March 17. Six of the eight were Asian-American. Preliminary details point to a shooter that targets Asian-owned businesses. Our community is living in fear a...
Tags: Facebook, News, White House, China, Southeast Asia, America, Atlanta, Diversity, Joe Biden, Taiwan, Fbi, Radio, Nepal, South America, Doj, Latest News


Early Study Results Suggest Experimental Drug Could Slow Cognitive Decline in Alzheimer's Patients

Eli Lilly and Company's experimental intravenous drug donanemab "could slow the cognitive decline of patients with Alzheimer's disease," reports CNN, citing early clinical trial results, published today in The New England Journal of Medicine: The study included 257 patients with early symptomatic Alzheimer's disease; 131 received donanemab, while 126 received a placebo. The researchers found donanemab slowed the decline of cognition and daily function in Alzheimer's patients by 32% after 76 wee...
Tags: Tech, Cnn, Eli Lilly and Company, Alzheimer, Alzheimer s Association, Carrillo, Maria Carrillo, Mark Mintun Eli Lilly


New data on Eli Lilly's experimental Alzheimer's drug backs a hotly debated scientific theory, but shows mixed benefits for patients

Patients sit inside the Alzheimer's Foundation in Mexico City Thomson Reuters Eli Lilly's experimental treatment slowed down cognitive decline by 32% in a midstage trial. But the drug missed most of the secondary trial goals, including one watched by experts. An Eli Lilly executive told Insider the data was mixed, but very exciting. See more stories on Insider's business page. The latest test of Eli Lilly's Alzheimer's disease drug ended with a mixed bag of results, bu...
Tags: California, Washington, Trends, Alzheimer's Disease, Healthcare, Fda, Pharmaceuticals, Morgan Stanley, CDR, US Food and Drug Administration, Lilly, Alzheimer, Biogen, Eli Lilly, Tanzi, Clinical Trial


This giant 1950s town replica in California is a new kind of treatment center for people with Alzheimer's

Glenner Town Square looks like a 1950s town, but it's actually a treatment center in Chula Vista, California for people with Alzheimer's disease and dementia. The center uses reminiscence therapy to help spark memories and provide a comforting environment for aging patients.  Participants rotate through a series of immersive activities, like playing bingo in a retro dinner or making jewelry in a clothing store, that keep their minds and bodies active. Visit Business Insider's homepage for more...
Tags: California, Trends, Healthcare, San Diego, Eva, Chula Vista, Scott, Town Square, Alzheimer, Sonia, Chula Vista California, Sonia She, Glenner Town Square, Alyssa Pagano, George Glenner, Joy Dr Glenner


Biogen soars 47% after FDA scientists say its Alzheimer's drug's efficacy is 'exceptionally persuasive'

A sign marks a Biogen facility in Cambridge Reuters Biogen soared as much as 47% on Wednesday after an FDA panel said on Wednesday that efficacy data for its Alzheimer's drug was "exceptionally persuasive."The comments from the FDA panel have given investors confidence that a swift approval of the drug is likely, based on Wednesday trades.Biogen's drug will be reviewed by independent experts at the FDA on Friday, who will then make recommendations to the agency.Watch Biogen trade live here....
Tags: Japan, Trends, Healthcare, Fda, Alzheimer, Biogen, Eisai Co, Matthew Fox, Cambridge Reuters Biogen, Watch Biogen


Root bacterium to fight Alzheimer's

A bacterium found among the soil close to roots of ginseng plants could provide a new approach for the treatment of Alzheimer's. Rhizolutin, a novel class of compounds with a tricyclic framework, significantly dissociates the protein aggregates associated with Alzheimer's disease both in vivo and in vitro, as reported by scientists in the journal Angewandte Chemie.
Tags: Science, Alzheimer


Where Writers Write: Lenore H. Gay

  Welcome to another installment of TNBBC's Where Writers Write! Where Writers Write is a series in which authors showcase their writing spaces using short form essay, photos, and/or video. As a lover of books and all of the hard work that goes into creating them, I thought it would be fun to see where the authors roll up their sleeves and make the magic happen.  This is Lenore H. Gay.  Lenore is a retired Licensed Professional Counselor. She ran a private counseling practice f...
Tags: Books, Richmond, Alzheimer, TNBBC, Lenore H Gay, Lenore H Gay Lenore, Blackbird An Online Journal, James River Writers Gay, Sasha Gay Overstreet


Only 35 percent of Americans know the symptoms of Alzheimer's disease

A new MDVIP/Ipsos survey found that only 35 percent of Americans know the symptoms of Alzheimer's disease.Eighty percent of respondents said they want to reduce their risks. An estimated 7.1 million Americans over the age of 65 will suffer from Alzheimer's by 2025. An estimated 5.8 million Americans over the age of 65 live with Alzheimer's disease. That number is increasing: within five years, The Alzheimer's Association predicts there will be 7.1 million. In 2020, $51.2 billion dollars in Med...
Tags: Diet, Memory, US, Neuroscience, Innovation, Exercise, Dementia, Alzheimer's, Medicaid, Mediterranean, Association, Derek, Twitter Facebook, Alzheimer, Boston University School of Medicine, Bryan James


El Universo: My Own Story

Reading helps to preserve the cognitive functions of people with Alzheimer's, that is why Diario El Universo decided to investigate and collect the most valuable memories of one of its oldest subscribers who suffers from this disease and turn them into news. For a month, Dora received her Diario El Universo with a page completely dedicated to her life. We made her own story part of her Alzheimer's treatment.
Tags: Advertising, Dora, Alzheimer, Diario El Universo


Unemployment diary: I'm a 25-year-old yoga teacher and painter in Montana who's been out of work since March

Becca DeMeyer. Courtesy of Becca DeMeyer; Shayanne Gal/Business Insider The Unemployed States of America takes readers deep inside the decimated American workforce. Becca DeMeyer is a 25-year-old yoga teacher based in Billings, Montana.  She was living in the Bahamas on a work exchange yoga program when COVID-19 began and evacuated back home to Montana in March.  She's been keeping busy as a painter and assisting her neighbor as a caretaker, and hopes to start teaching yoga again, either i...
Tags: Montana, US, America, Trends, Strategy, Canada, Unemployment, Bahamas, Nordic, Alzheimer, Ty, Billings Montana, Juliana Kaplan, Coronavirus, BI-freelancer, Contributor 2019


Study examines if Alzheimer's disease and related Dementias affect delirium severity

Forms of dementia, including Alzheimer's disease, gradually affect your cognitive function by harming your memory and your ability to think and make decisions.
Tags: Health, Alzheimer


Woman took dishwashing job so she could visit husband with Alzheimer's during pandemic

Mary Daniel visited her husband Steve every day at his Florida memory care center until they stopped allowing visitors in March because of the coronavirus pandemic.
Tags: Florida, News, Stories, Steve, Alzheimer, Mary Daniel


Florida woman took dishwashing job so she could visit husband with Alzheimer's during pandemic

Mary Daniel visited her husband Steve every day at his Florida memory care center until they stopped allowing visitors in March because of the coronavirus pandemic.
Tags: Florida, Cnn, Steve, Alzheimer, Mary Daniel


New research paves way for developing therapies that could slow down Alzheimer's

Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer's disease pathology. The study has been published in Stem Cell Reports.
Tags: Science, Sweden, Alzheimer, Lund University


Common Herpes Virus Causes Signs of Alzheimer's Disease In Brain Cells

An anonymous reader quotes a report from New Scientist: Mini-brains grown in a dish rapidly develop signs of Alzheimer's disease when infected with the common herpes virus that causes cold sores. The finding adds to growing evidence that some cases of Alzheimer's disease are triggered by viruses and could potentially be treated with antiviral drugs. To understand how Herpes simplex virus-1 (HSV-1) might cause Alzheimer's disease, Dana Cairns at Tufts University in the U.S., and her colleagues ad...
Tags: Tech, HSV, Tufts University, Alzheimer, Dana Cairns


Novel imaging technique sheds light on Alzheimer's disease

To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.
Tags: Health, Alzheimer


New imaging method sheds light on Alzheimer's disease

To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease. Researchers at Lund University in Sweden have tested a new imaging method for this purpose. The research is published in the journal Advanced Science.
Tags: Science, Sweden, Alzheimer, Lund University